
Phu Hoang Nguyen
Examiner (ID: 14741, Phone: (571)272-5931 , Office: P/1747 )
| Most Active Art Unit | 1747 |
| Art Unit(s) | 1731, 1747, 1791 |
| Total Applications | 942 |
| Issued Applications | 511 |
| Pending Applications | 112 |
| Abandoned Applications | 343 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18482831
[patent_doc_number] => 20230210116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => HONEYBEE REPELLENT
[patent_app_type] => utility
[patent_app_number] => 17/999038
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999038 | HONEYBEE REPELLENT | May 17, 2021 | Abandoned |
Array
(
[id] => 19246781
[patent_doc_number] => 20240197765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => Antiviral compositions comprising liposome-encapsulated ascorbyl glucoside and natural extracts
[patent_app_type] => utility
[patent_app_number] => 18/556171
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556171
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556171 | Antiviral compositions comprising liposome-encapsulated ascorbyl glucoside and natural extracts | May 12, 2021 | Pending |
Array
(
[id] => 17314362
[patent_doc_number] => 20210403410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => OPHTHALMIC FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/318581
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318581 | OPHTHALMIC FORMULATION | May 11, 2021 | Abandoned |
Array
(
[id] => 18737807
[patent_doc_number] => 20230346703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Myelin Nanovesicles And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/925262
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925262 | Myelin Nanovesicles And Uses Thereof | May 11, 2021 | Pending |
Array
(
[id] => 19316902
[patent_doc_number] => 20240238442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => LIPOSOMES DISPLAYING A GLYCAN LIGAND FOR CD33 AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/558999
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558999
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/558999 | LIPOSOMES DISPLAYING A GLYCAN LIGAND FOR CD33 AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE | May 4, 2021 | Pending |
Array
(
[id] => 17198529
[patent_doc_number] => 20210338623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => COMPOSITIONS COMPRISING N-ACETYL METHYL GABA AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/245861
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245861
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245861 | Compositions comprising N-acetyl methyl GABA and related methods | Apr 29, 2021 | Issued |
Array
(
[id] => 17034802
[patent_doc_number] => 20210251760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Reinforced Bone Scaffold
[patent_app_type] => utility
[patent_app_number] => 17/240562
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240562 | Reinforced bone scaffold | Apr 25, 2021 | Issued |
Array
(
[id] => 18374491
[patent_doc_number] => 20230149570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => METAL NUCLIDE-LOADED CARBON MICROSPHERE (CMS), PREPARATION METHOD, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/916091
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916091
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916091 | Metal nuclide-loaded carbon microsphere (CMS), preparation method, and use thereof | Apr 22, 2021 | Issued |
Array
(
[id] => 17206558
[patent_doc_number] => 11166909
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-11-09
[patent_title] => Liposomal nanoparticle essential oil composition for nostril administration
[patent_app_type] => utility
[patent_app_number] => 17/234863
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9260
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234863
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/234863 | Liposomal nanoparticle essential oil composition for nostril administration | Apr 19, 2021 | Issued |
Array
(
[id] => 19246993
[patent_doc_number] => 20240197977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => IMPROVED IMMUNE RESPONSE AND DECREASED IMMUNOPARALYSIS WITH IMMUNOMODULATING TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/919053
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -75
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/919053 | IMPROVED IMMUNE RESPONSE AND DECREASED IMMUNOPARALYSIS WITH IMMUNOMODULATING TREATMENT | Apr 13, 2021 | Pending |
Array
(
[id] => 18909349
[patent_doc_number] => 11872312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Neuroprotective liposome compositions and methods for treatment of stroke
[patent_app_type] => utility
[patent_app_number] => 17/229627
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12649
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229627
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/229627 | Neuroprotective liposome compositions and methods for treatment of stroke | Apr 12, 2021 | Issued |
Array
(
[id] => 18626505
[patent_doc_number] => 20230285291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => MANUFACTURING OF SYNTHETIC EXOSOMES FOR CNS AND NON-CNS DELIVERY OF THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 17/917233
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917233 | MANUFACTURING OF SYNTHETIC EXOSOMES FOR CNS AND NON-CNS DELIVERY OF THERAPEUTICS | Apr 5, 2021 | Pending |
Array
(
[id] => 19947067
[patent_doc_number] => 12318405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Combined pharmaceutical formulation comprising drug-containing liposome composition and platinum preparation
[patent_app_type] => utility
[patent_app_number] => 17/219064
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11966
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219064 | Combined pharmaceutical formulation comprising drug-containing liposome composition and platinum preparation | Mar 30, 2021 | Issued |
Array
(
[id] => 19947067
[patent_doc_number] => 12318405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Combined pharmaceutical formulation comprising drug-containing liposome composition and platinum preparation
[patent_app_type] => utility
[patent_app_number] => 17/219064
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11966
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219064 | Combined pharmaceutical formulation comprising drug-containing liposome composition and platinum preparation | Mar 30, 2021 | Issued |
Array
(
[id] => 16976277
[patent_doc_number] => 20210220514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => KITS FOR PREPARING A REACTIVE GRAFT MATERIAL AND INJECTING THE GRAFT MATERIAL INTO A PATIENT
[patent_app_type] => utility
[patent_app_number] => 17/219763
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219763
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219763 | KITS FOR PREPARING A REACTIVE GRAFT MATERIAL AND INJECTING THE GRAFT MATERIAL INTO A PATIENT | Mar 30, 2021 | Abandoned |
Array
(
[id] => 19947067
[patent_doc_number] => 12318405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Combined pharmaceutical formulation comprising drug-containing liposome composition and platinum preparation
[patent_app_type] => utility
[patent_app_number] => 17/219064
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11966
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219064 | Combined pharmaceutical formulation comprising drug-containing liposome composition and platinum preparation | Mar 30, 2021 | Issued |
Array
(
[id] => 19947067
[patent_doc_number] => 12318405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Combined pharmaceutical formulation comprising drug-containing liposome composition and platinum preparation
[patent_app_type] => utility
[patent_app_number] => 17/219064
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11966
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219064 | Combined pharmaceutical formulation comprising drug-containing liposome composition and platinum preparation | Mar 30, 2021 | Issued |
Array
(
[id] => 16961454
[patent_doc_number] => 20210212953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => STABILIZATION OF BETA-HYDROXYISOVALERIC ACID FORMULATIONS IN SOFT GEL CAPSULES
[patent_app_type] => utility
[patent_app_number] => 17/217913
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17217913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/217913 | Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules | Mar 29, 2021 | Issued |
Array
(
[id] => 18373577
[patent_doc_number] => 20230148653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => ARECOLINE SALT AND PREPARATION METHOD AND PRODUCT THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/914842
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914842 | ARECOLINE SALT AND PREPARATION METHOD AND PRODUCT THEREOF | Mar 25, 2021 | Pending |
Array
(
[id] => 19310503
[patent_doc_number] => 12036297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Deep-sea water concentrate skin application kit and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/212378
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 7567
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212378 | Deep-sea water concentrate skin application kit and use thereof | Mar 24, 2021 | Issued |